Day 2 – Wednesday, 17 Sept 2025Wednesday, September 17, 2025 - ET (Eastern Time, GMT-05:00)

In today's digital age, the lines between commercial operations, R&D, and customer engagement are blurring. This panel explores how shared digital technologies can break down internal silos within pharma while simultaneously enhancing customer experiences. We'll discuss the strategic implementation of unified platforms, data-driven approaches, and seamless digital interactions to create a cohesive and patient-centric ecosystem.

• How can we break down the silos between Commercial & R&D for pharma success?
• Discussing how integrated data platforms and AI-powered analytics can facilitate faster decision-making and streamline the drug development process
• Exploring how shared digital tools can provide real-time market insights, patient feedback, and payer data to optimize product positioning and launch strategies
• Examining the importance of fostering a culture of cross-functional collaboration and digital literacy to ensure the successful implementation and adoption of shared technologies

Explore how pharmaceutical companies are leveraging generative AI to revolutionize omnichannel engagement. This panel will discuss how AI-driven analytics and technology are illuminating hidden insights in data, enabling hyper-personalization, and driving better health outcomes. Discover how pharma is orchestrating personalized communications and interactions that resonate with stakeholders at every stage of their journey.

• Understanding the evolution and the importance of a coordinated omnichannel approach in pharma marketing and communications
• Discussing how generative AI can rapidly produce tailored content, enhance field force training, and provide 24/7 support to HCPs and patients
• Exploring strategies to address challenges in AI implementation, fostering cross-functional collaboration, and ensuring data quality and ethical use

Explore the transformative power of AI in Medical Affairs. This panel delves into how AI-driven insights are enhancing strategic decision-making, streamlining operations, and ultimately improving patient outcomes. Discover how Medical Affairs teams are leveraging AI to navigate the complexities of the digital landscape and deliver impactful results.

• How AI is enabling Medical Affairs teams to efficiently analyse vast amounts of data, identify key trends, and generate actionable insights
• Discussing how AI-powered tools are improving communication and collaboration with healthcare professionals, patients, and other stakeholders
• Exploring how AI-driven insights are informing key decisions in Medical Affairs, leading to more effective strategies and improved outcomes

Technologies like artificial intelligence (AI) and machine learning are now shaping the future of the life sciences industry – and data is the foundation that drives these technologies forward. However, without the right tools to help manage and process it, the best data in the world can quickly become useless.

• What are the biggest challenges to centralizing, standardizing, and managing data? How are pharma overcoming those challenges?
• What is the next frontier when it comes to data-driven solutions? What are the tools being developed right now that will transform the way we approach healthcare?
• What role does AI play in this? Where do you see the most potential for healthcare to benefit from the current AI tide?